Vanda Pharmaceuticals Inc. — DEF 14A

Vanda Pharmaceuticals Inc. of WASHINGTON, DC filed a DEF 14A with the SEC on 2023-04-24. Industry: Pharmaceutical Preparations.

Filing

Documents (12)

SeqTypeDescription
1DEF 14ADEF 14A
2EX-101.SCHXBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
3EX-101.DEFXBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
4EX-101.LABXBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
5EX-101.PREXBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
6GRAPHICvnda-20230424_g1.jpg
7GRAPHICvnda-20230424_g2.jpg
8GRAPHICvnda-20230424_g3.jpg
9GRAPHICvnda-20230424_g4.jpg
10GRAPHICvnda-20230424_g5.jpg
11GRAPHICvnda-20230424_g6.jpg
14XMLEXTRACTED XBRL INSTANCE DOCUMENT

Filing timeline for this registrant (44)

Showing 12 of 44 filings.

FiledForm
2026-04-23DEFA14A
2026-04-23DEF 14A
2025-05-27DEFA14A
2025-04-25DEFA14A
2025-04-25DEF 14A
2024-05-13DEFA14A
2024-05-09DEFA14A
2024-04-29DEF 14A
2023-04-24DEFA14A
2023-04-24DEF 14A
2022-04-25DEFA14A
2022-04-25DEF 14A

More